All News Zynex, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-19 pm EDT			5-day change	1st Jan Change
11.38 ^USD	-0.61%		-4.45%	+4.50%

Mar. 01	RBC Raises Price Target on Zynex to $15 From $13, Keeps Outperform Rating	MT
Feb. 29	Zynex, Inc. Provides Earnings Guidance First Quarter and Full Year 2024	CI

Zynex Sets First Quarter 2024 Earnings Call	Apr. 18	PR
Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award	Apr. 02	PR
Zynex Reports Fourth Quarter and Full Year 2023 Financial Results	Mar. 01	AQ
RBC Raises Price Target on Zynex to $15 From $13, Keeps Outperform Rating	Mar. 01	MT
Zynex, Inc. Provides Earnings Guidance First Quarter and Full Year 2024	Feb. 29	CI
Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on September 11, 2023.	Feb. 29	CI
Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on November 1, 2023.	Feb. 29	CI
Zynex, Inc. announces an Equity Buyback for $20 million worth of its shares.	Feb. 29	CI
Transcript : Zynex, Inc., Q4 2023 Earnings Call, Feb 29, 2024	Feb. 29
Earnings Flash (ZYXI) ZYNEX Reports Q4 Revenue $47.3M, vs. Street Est of $55.6M	Feb. 29	MT
Zynex, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 29	CI
Zynex, Inc. authorizes a Buyback Plan.	Feb. 28	CI
Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call	Feb. 22	PR
Zynex Introduces New Products	Feb. 20	PR
Zynex, Inc. Introduces New Products	Feb. 20	CI
Zynex Receives FDA Clearance for its Next Generation NMES Device	Feb. 07	AQ
Zynex Receives US FDA Approval for Muscle Stimulation Device	Feb. 06	MT
Zynex, Inc. Receives FDA Clearance for its Next Generation NMES Device	Feb. 06	CI
Zynex Recognized in Top 25 Medical Device Companies for 2024	Feb. 02	PR
Zynex to Participate at the Needham Annual Growth Conference	Jan. 08	PR

No results for this search